Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer
Titel:
Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer
Auteur:
Delpech, Y. Wu, Y. Hess, K. R. Hsu, L. Ayers, M. Natowicz, R. Coutant, C. Rouzier, R. Barranger, E. Hortobagyi, G. N. Mauro, D. Pusztai, L.